| Updated on April 10, 2015 Published on April 10, 2015

Aurobindo Pharma Ltd has informed BSE that Aurobindo Pharma Limited (APL) has divested its step-down subsidiary, Aurobindo Pharma (Australia) Pty Ltd to Eris Pharma Australia Pty Ltd. APL will, however, under an agreement continue to manufacture and supply the products to Eris Pharma for Australian and New Zealand market over next few years. This divestment is in line with APLs Strategy of focusing on US, EU and Key Emerging Markets. This subsidiary was not contributing any profit to Aurobindo.

Source : BSE - >www.bseindia.com

Published on April 10, 2015
This article is closed for comments.
Please Email the Editor